Jessica R Grubb

Reply to Ganesan et al.

J. Grubb, E. Overton, R. Presti, 2012, The Journal of infectious diseases.

The changing spectrum of pulmonary disease in patients with HIV infection on antiretroviral therapy

H. Masur, A. Moorman, J. Grubb, 2006, AIDS.

Patterns of primary antiretroviral drug resistance in antiretroviral-naive HIV-1-infected individuals in a midwest university clinic

W. Powderly, E. Overton, K. Mondy, 2006, AIDS.

Transmitted drug-resistant HIV type 1 remains prevalent and impacts virologic outcomes despite genotype-guided antiretroviral therapy.

E. Overton, N. Önen, E. Shacham, 2012, AIDS Research and Human Retroviruses.

Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population.

K. Yarasheski, W. Powderly, E. Overton, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pravastatin does not have a consistent antiviral effect in chronically HIV-infected individuals on antiretroviral therapy.

H. Masur, E. Freed, A. Ono, 2005, AIDS.

Depression severity is associated with increased risk behaviors and decreased CD4 cell counts

E. Overton, N. Önen, E. Shacham, 2014, AIDS care.

Causative and contributive factors to asthma severity and patterns of medication use in patients seeking specialized asthma care.

K. Schechtman, D. Hamilos, Aimee Liou, 2003, Chest.

Efavirenz Outperforms Boosted Atazanavir among Treatment-Naive HIV-1-Infected Persons in Routine Clinical Care

E. Overton, N. Önen, E. Shacham, 2013, Journal of the International Association of Providers of AIDS Care.

Lopinavir-ritonavir: effects on endothelial cell function in healthy subjects.

M. Gladwin, J. Kovacs, H. Masur, 2006, The Journal of infectious diseases.